These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34732626)

  • 1. [Reagent-dependent pseudo-prolongation of activated partial thromboplastin time].
    Miyazaki S; Nishida Y; Asagiri T; Shigetome K; Kida K; Hisakawa H; Togitani K; Kojima K
    Rinsho Ketsueki; 2021; 62(10):1515-1518. PubMed ID: 34732626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis on characteristics of two activated partial thromboplastin time reagents.
    Yasui Y; Ishii T; Tatebe J; Morita T
    J Clin Lab Anal; 2022 Sep; 36(9):e24608. PubMed ID: 35853032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference.
    Okuda M; Yamamoto Y
    Clin Lab Haematol; 2004 Jun; 26(3):215-23. PubMed ID: 15163321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutions.
    Barna L; Triplett DA
    Ric Clin Lab; 1989; 19(4):345-54. PubMed ID: 2517350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodical aspects of blood coagulation measurements in birds applying commercial reagents--a pilot study.
    Guddorf V; Kummerfeld N; Mischke R
    Berl Munch Tierarztl Wochenschr; 2014; 127(7-8):322-7. PubMed ID: 25080826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer.
    Shetty S; Ghosh K; Mohanty D
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):493-7. PubMed ID: 12851537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artifactual prolongation of the activated partial thromboplastin time mimicking a coagulopathy. A lesson relearned.
    Humphries JE; Acker MN; Schnell DE; Knarr JW
    Am J Clin Pathol; 1993 Aug; 100(2):108-10. PubMed ID: 8356940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
    Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
    Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of Quick, partial thromboplastin time, and Co].
    Siegert G
    Internist (Berl); 2014 May; 55(5):506, 508, 510-3. PubMed ID: 24781934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor.
    Harenberg J; Reichel T; Malsch R; Hirsh J; Rustagi P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):453-8. PubMed ID: 8839997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies.
    Turi DC; Peerschke EI
    Am J Clin Pathol; 1986 Jan; 85(1):43-9. PubMed ID: 3940420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios.
    Naghibi F; Han Y; Dodds WJ; Lawrence CE
    Thromb Haemost; 1988 Jun; 59(3):455-63. PubMed ID: 3187932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incompatibility of a recombinant thromboplastin and an APTT reagent on a fully automated coagulation analyzer.
    Kappelmayer J; Ajzner E; Muszbek L
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):251-2. PubMed ID: 9199824
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs.
    Tseng LW; Hughes D; Giger U
    Am J Vet Res; 2001 Sep; 62(9):1455-60. PubMed ID: 11560277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of coagulation time: PT and APTT].
    Ramakers C; van der Heul C; van Wijk EM
    Ned Tijdschr Geneeskd; 2012; 156(0):A3985. PubMed ID: 22917038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations.
    Rosove MH; Ismail M; Koziol BJ; Runge A; Kasper CK
    Blood; 1986 Aug; 68(2):472-8. PubMed ID: 3730611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive.
    Tientadakul P; Kongkan C; Chinswangwatanakul W
    Arch Pathol Lab Med; 2013 Nov; 137(11):1641-7. PubMed ID: 24168503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding.
    Murray D; Pennell B; Olson J
    Transfusion; 1999 Jan; 39(1):56-62. PubMed ID: 9920167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.